B222c4

General

Cell Line

hPSCreg name PFIZi029-A
Cite as:
PFIZi029-A (RRID:CVCL_VE77)
Alternative name(s)
B222c4
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
NIHTVBi019-A
(HT852)
Donor diseases:
Leukodystrophy
PUFHi004-A
(TMEM163 c.227T>C p.(Leu76Pro) iPSC)
Donor's gene variants:
TMEM 163
Donor diseases:
Leukodystrophy
SHCDNi006-A
(SHCDN006)
Donor diseases:
epilepsy
PFIZi023-A
(B217c8)
Donor's gene variants:
GPR56, GPR56
Donor diseases:
Bilateral Frontoparietal Polymicrogyria
PFIZi025-A
(B220c16)
Donor's gene variants:
KCNC1
Donor diseases:
epilepsy
LZUSHi001-A
(ips98)
Donor diseases:
Generalized Epilepsy
PNUSCRi004-A
(GBA PD iPSC8)
Donor diseases:
Parkinson's Disease
SIAISi006-A
(JJY)
Donor diseases:
Alzheimer's Disease
MUNIi021-A
(sAD5)
Donor diseases:
Alzheimer's Disease
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
JUCGRMi003-A
(PH13)
Donor diseases:
Parkinson's Disease
MUNIi011-A
(BAD1, sAD1)
Donor diseases:
Alzheimer's Disease
MUNIi012-A
(BAD2, sAD2)
Donor diseases:
Alzheimer's Disease
UMi041-A
(410730)
Donor diseases:
Alzheimer's Disease
JUCGRMi002-A
(DupA5)
Donor diseases:
Parkinson's Disease
JUCGRMi002-B
(DupA13)
Donor diseases:
Parkinson's Disease
BIOTi001-A
(BIOT-7183-PSEN1)
Donor's gene variants:
PSEN1
Donor diseases:
obsolete_Alzheimer's disease
JUCGRMi002-C
(DupA18)
Donor diseases:
Parkinson's Disease
IPTi002-A
(15F0009)
Donor diseases:
obsolete_Alzheimer's disease
LNDWCHi001-A
(LNDWCH-iPS-PD-PLA2G6–001)
Donor diseases:
Parkinson Disease
UMi043-A
(AD 381852 clone #1)
Donor diseases:
Alzheimer's Disease
CBIGi002-A
(2890 (GBA W378G, heterozygous), 2890)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson's Disease
CBIGi003-A
(3026, 3026 (GBA N370S, heterozygous))
Donor diseases:
Parkinson's Disease
Last update 4th February 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Pfizer Limited - Pfizer (PFIZ)
Distributors

External Databases

BioSamples SAMEA104491453
Cellosaurus CVCL_VE77
Wikidata Q54947283

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 5-9

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Myoclonic encephalopathy
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Myoclonic Epilepsy, Infantile, Benign
  • Epilepsy, Myoclonic, Infantile, Benign
  • Symptomatic Myoclonic Epilepsy
  • Myoclonic Seizure Disorder
  • Severe Infantile Myoclonic Epilepsy
  • Myoclonic Epilepsy, Severe Infantile
  • Benign Infantile Myoclonic Epilepsy
  • Epilepsy, Myoclonic, Infantile, Severe
  • Myoclonic Absence EpilepsyMyoclonic Astatic Epilepsy
  • Early Childhood Epilepsy, Myoclonic
  • Myoclonic Epilepsy
  • Epilepsy, Early Childhood, Myoclonic
  • Epilepsy, Myoclonic, Infantile
  • Severe Myoclonic Epilepsy, Infantile
  • Myoclonic Epilepsy, Infantile, Severe
  • Epilepsy, Myoclonic, Early Childhood
  • Myoclonic Epilepsy, Benign InfantileMyoclonic Epilepsy, Early Childhood
  • Encephalopathy, Myoclonic
  • Myoclonic Encephalopathy
  • Severe Myoclonic Epilepsy Of Infancy
  • Myoclonic Epilepsy, Infantile
  • Myoclonic Epilepsy, Severe, Of Infancy
  • Infantile Severe Myoclonic Epilepsy
  • Early Childhood, Myoclonic Epilepsy
  • Epilepsy, Myoclonus
  • Idiopathic Myoclonic Epilepsy
  • Cryptogenic Myoclonic Epilepsy
show more synonyms
Genetic variants
CHD2 (target)
15q26.1
NM_001271.3:c.4636C>T
NP_001262.3:p.Arg1546Ter
SCV000573177.3
c4636 C>T in exon 36 of the CHD2 gene (NM_001271.3)

External Databases (Donor)

BioSamples SAMEA104491454

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent are available? Yes
Alternatives to consent
Alternative consent approval number
Is there other documentation provided to the donor for consenting purposes? No
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? NYU Institutional Review Board
Approval number i14-01725
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? NYU Institutional Review Board
Approval number i14-01725
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
Age of donor (at collection) 5-9

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SSEA-4
Yes
TRA 1-60
Yes
SSEA-1
No
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
No
GATA6
Yes
CXCR4
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Vimentin
Yes
NCAM
Yes
MIXL1
Yes
Ectoderm
Ont Id: UBERON_0000924
Marker Expressed
PAX6
Yes
NeuroD1
Yes
HES5
Yes

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage: 16

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XX modal karyotype in 20 cells showed a normal female chromosome and complement banding pattern
Passage number: 19
Karyotyping method: G-Banding

Other Genotyping (Cell Line)